DIM
DGX icon

DLK Investment Management’s Quest Diagnostics DGX Stock Holding History

DLK Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.22M Hold
5,248
– – 0.45% 39
2026
Q2 		$718K Hold
5,248
– – 0.31% 47
2026
Q1 		$1.03M Hold
5,248
– – 0.41% 40
2025
Q4 		$911K Hold
5,248
– – 0.34% 44
2025
Q3 		$1M Hold
5,248
– – 0.38% 42
2025
Q2 		$943K Hold
5,248
– – 0.36% 43
2025
Q1 		$888K Hold
5,248
– – 0.37% 41
2024
Q4 		$792K Hold
5,248
– – 0.33% 43
2024
Q3 		$815K Hold
5,248
– – 0.31% 46
2024
Q2 		$718K Buy
5,248
+100
+2% +$13.7K 0.3% 48
2024
Q1 		$685K Buy
5,148
+70
+1% +$9.08K 0.29% 45
2023
Q4 		$700K Buy
+5,078
New +$668K 0.32% 45

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

DLK Investment Management's DGX Position: Q3 2026 in Review

DLK Investment Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 5,248 shares worth $1.22M. The position accounts for 0.45% of the portfolio, ranked #39.

DLK Investment Management first reported a position in DGX in Q4 2023 and has held it in 12 quarters since. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • DLK Investment Management held 5,248 shares of Quest Diagnostics worth $1.22M as of Q3 2026.
  • DLK Investment Management left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.45% of DLK Investment Management's portfolio in Q3 2026, its #39 holding.
  • DLK Investment Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 12 quarters since.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on DLK Investment Management's 13F filing for Q3 2026, filed 9 Oct 2026.